Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I ADME Study of [14C]-sivopixant in Healthy Adult Males
jRCT1080225285Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of sivopixant in refractory chronic cough (RCC), sponsored by Shionogi & Co., Ltd. Primary endpoint: Primary ADME parameters of [14C]-sivopixant. Started Jul 2020; status: completed.
02
Drugs
sivopixant
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on jRCT1080225285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225285.